Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Asian Shares Mixed Despite US-China Trade Deal Optimism

Tue, 08th Jan 2019 08:58

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in Beijing.

The second day of negotiations coincided with an unannounced visit by North Korean leader Kim Jong Un, with some analysts saying China could use Kim's visit as a bargaining chip in the US trade talks.

China's Shanghai Composite index slid 0.26% to 2,526.46 while Hong Kong's Hang Seng index rose 0.15% to 25,875.45.

Japanese shares ended on a positive note after Amazon and Microsoft Corp fueled a second straight session of gains on Wall Street overnight.

The Nikkei average gained 165.07 points or 0.82% to finish at 20,204.04 while the broader Topix index closed 0.39% higher at 1,518.43.

Automaker Honda Motor rallied 3.2% and Toyota rose 1.2% while banks Mitsubishi UFJ Financial, Sumitomo Mitsui Financial and Mizuho Financial rose between 0.3% and 1.3%.

Takeda Pharmaceutical climbed 2.3% after completing its acquisition of Irish drugmaker Shire. Inpex and Japan Petroleum gained around 1% after crude oil prices rose more than 1% overnight.

Olympus Corp jumped 8.4% after Morgan Stanley upgraded the stock's rating to "overweight" from "equal-weight".

Seoul stocks fell as investors monitored the second day of trade talks between China and the US. The benchmark Kospi dropped 11.83 points or 0.58% to 2,025.27. Samsung Electronics lost 1.7% after it partnered with tech giant Apple Inc. to bring iTunes content to Samsung smart televisions.

On the data front, South Korea posted a current account surplus of USD5.06 billion in November, the Bank of Korea said - down from the USD9.19 billion surplus in October. The goods account surplus stood at USD7.97 billion, down from USD11.46 billion in November 2017.

Australian markets closed notably higher amid signs that Beijing and Washington may be inching closer toward a trade deal.

Traders shrugged off weak trade data showing that the country had a seasonally adjusted merchandise trade surplus of AUD1.925 billion in November, shy of expectations for a surplus of AUD2.175 billion and down from AUD2.316 billion in October.

The benchmark S&P/ASX 200 index rose 39.20 points or 0.69% to 5,722.40 while the broader All Ordinaries index ended higher by 38.80 points or 0.68% at 5,783.30.

Banks ANZ, NAB and Westpac rose between 0.9% and 1.2%. Waste management giant Bingo Industries soared 5.7% after it offered to sell its Sydney processing plant to address antitrust concerns related to the planned acquisition of Dial-aDump.

Gold miner Evolution lost 3.4%, St Barbara tumbled 5% and Northern Star Resources declined 2.6% as dovish comments from the Fed boosted investors' appetite for risk.

Sleep device maker ResMed advanced 1.4% after completing the USD225 million acquisition of US-based asthma and pulmonary specialist Propeller Health.

New Zealand shares rose modestly, with the benchmark S&P/NZX 50 index finishing up 15.11 points or 0.17% at 8,821.15.

U.S stocks rose overnight as the US and China resumed talks on their trade war and Federal Reserve Chair Jerome Powell said the central bank would be "flexible" in its approach to monetary policy.

The Dow Jones Industrial Average rose 0.4%, the tech-heavy Nasdaq Composite rallied 1.3% and the S&P 500 climbed 0.7%.

More News
7 Dec 2016 15:08

Broker tips: Shire, GKN, IG Group

(ShareCast News) - UBS downgraded Shire to 'neutral' from 'buy' and cut the price target to 5,000p from 5,600p saying a tougher environment for expensive orphan drugs was likely to constrain performance. This, and other issues such as low return on invested capital and the 2023 Vyvanse patent expiry

Read more
7 Dec 2016 14:03

UBS downgrades Shire on orphan drug concerns

(ShareCast News) - UBS downgraded Shire to 'neutral' from 'buy' and cut the price target to 5,000p from 5,600p saying a tougher environment for expensive orphan drugs was likely to constrain performance. This, and other issues such as low return on invested capital and the 2023 Vyvanse patent expiry

Read more
7 Dec 2016 10:46

BUZZ-European Pharma: UBS shuffles recommendations

** UBS analysts say investors in healthcare stocks should seek exposure to oncology and new expensive drugs which displace older expensive drugs; avoid therapy areas at risk of becoming crowded and new drugs with high budget impact ** Brokerage double upgrades to "buy" from "sell" Novo Nord

Read more
7 Dec 2016 09:33

BROKER RATINGS SUMMARY: Credit Suisse Raises Rio Tinto And Cuts BHP

Read more
7 Dec 2016 08:23

LONDON BRIEFING: Pound Slips As UK's May Asks For Article 50 Support

Read more
1 Dec 2016 09:42

Pharma stocks to outperform versus Miners as US dollar gains, Deutsche Bank says

(ShareCast News) - Pharmaceuticals' recent underperformance versus Mining stocks might be set to end, strategists at Deutsche Bank said. The approximately 5% gain in the US dollar index over the past three months would have been consistent with double-digit outperformance by the former, the investme

Read more
28 Nov 2016 12:34

Actelion's ambitious independent-minded CEO will drive up takeover price

* Need for premium could lift price to $26 bln, analysts say * J&J has had preliminary talks with Swiss biotech firm * Actelion could also appeal to deal-hungry Sanofi By John Miller ZURICH, Nov 28 (Reuters) - Actelion Chief Executive Jean-Paul Clozel's desire to keep Euro

Read more
22 Nov 2016 17:01

Shire to build innovation hub in Massachusetts

(ShareCast News) - Irish pharmaceutical company Shire announced that it will expand its operations in Cambridge, Massachusetts through the establishment of an innovation hub to study rare diseases. Shire and BioMed Realty have signed a lease for a 343,00 square foot building at 500 Kendall street ca

Read more
14 Nov 2016 18:15

REUTERS SUMMIT-Omega's Einhorn sees Trump's policies boosting stocks

Read more
11 Nov 2016 12:19

LONDON MARKET MIDDAY: Trump Rally Cools Ahead Of Risk-Off Weekend

Read more
11 Nov 2016 11:56

Shire sees opportunity in Asia, aims to double revenue by 2020

By Clara Ferreira-Marques SINGAPORE, Nov 11 (Reuters) - Shire, a specialist in rare diseases, aims to double Asian sales by 2020, as it targets markets including China, where it hopes to put its haemophilia drugs on a reimbursement list being updated this year for the first time since 2009.

Read more
11 Nov 2016 09:55

Friday broker round-up

(ShareCast News) - Imperial Brands: JP Morgan keeps at neutral with a target price of 3660p. Standard Life: Berenberg stays at buy 416p target. Barclays: Societe Generale upgrades to buy with a 235p target. UBM: Barlcays reiterates equal-weight with a 755p target. Derwent London: Goldman Sachs ke

Read more
9 Nov 2016 19:36

UPDATE 4-Pharma, biotech shares soar as Trump win calms pricing talk

* Clinton had been seen more likely to rein in drug costs * California drug pricing initiative heading for defeat * Hospital shares crushed on Obamacare rollback worries (Adds background on biotechs, analyst comment, updates share moves) By Lewis Krauskopf and Ben HirschlerRead more

9 Nov 2016 17:20

Britain's FTSE recovers from Trump shock to hit one-week high

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets) * FTSE 100 index closes 1 pct higher * Miners, pharma stocks rally * U.S.-exposed firms also gain By Atul Prakash and Kit R

Read more
9 Nov 2016 15:17

Sector movers: Miners, US election-related plays lead gains

(ShareCast News) - Steel and mining stocks led gains for another session, amid widespread gains for most base metals and coal, helped by an initial bout of weakness in the US dollar. As of 1650 GMT, the US dollar was trading higher by 0.47% to 98.32 points after having earlier hit an intra-day low a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.